Evaluation of C-Reactive Protein in Urinary Tract Infected Patients Attending Madonna University Teaching Hospital
DOI:
https://doi.org/10.64229/9czdpm48Keywords:
C-Reactive Protein, Urinary Tract, Infected PatientsAbstract
This study was carried out to determine the level of C-reactive protein (CRP) in Urinary Tract infection Patients attending Madonna University Teaching Hospital. C- reactive protein was measured using the ELISA (Enzyme-Linked Immunosorbent Assay) method. The statistical software for social sciences (SPSS) version 26 was used to statistically analyze the data acquired from this study. C- reactive protein values in the UTI group (20.75±8.35 mg/L) were significantly higher than those in the control group (3.08±1.28 mg/L), demonstrating a strong inflammatory response to UTIs. Additionally, age-related study showed that children and adolescents had greater CRP levels than adults. Patients with Escherichia coli showed considerably higher CRP levels than Klebsiella pneumoniae and Proteus mirabilis in the bacterial growth categories, however no significant difference was seen between Klebsiella pneumoniae and Proteus mirabilis. Differences in immune response dynamics, pathogen pathogenicity, and host-pathogen interactions can be used to explain these variances in CRP levels. The results show how useful CRP is as an inflammatory marker in UTIs.
References
[1]Pope, J. E., & Choy, E. H. (2021). C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. In Seminars in arthritis and rheumatism (Vol. 51, No. 1, pp. 219-229). WB Saunders.
[2]Sheriff, A., Kayser, S., Brunner, P., & Vogt, B. (2021). C-reactive protein triggers cell death in ischemic cells. Frontiers in immunology, 12: 630430.
[3]Carbo, J. F., Ruh, C. A., Kurtzhalts, K. E., Ott, M. C., Sellick, J. A., & Mergenhagen, K. A. (2016). Male veterans with complicated urinary tract infections: Influence of a patient-centered antimicrobial stewardship program. American Journal of Infection Control, 44 (12): 1549-1553.
[4]Charles, M., Clyne, B., Olshaker, J. S., The C-reactive protein. J Emerg Med. 1974, 17 (6):1019–1025
[5]Skow, M. A., Vik, I., & Høye, S. (2020). Antibiotic switch after treatment with UTI antibiotics in male patients. Infectious Diseases, 52 (6): 405-412.
[6]Keren, R., Shaikh, N., Pohl, H., Gravens-Mueller, L., Ivanova, A., Zaoutis, L., & Hoberman, A. (2015). Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics, 136 (1): e13-e21.
[7]Kline, K. A., & Lewis, A. L. (2017). Gram‐positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, 459-502.
[8]Geerlings, S. E. (2017). Clinical presentations and epidemiology of urinary tract infections. Urinary tract infections: Molecular pathogenesis and clinical management, 27-40.
[9]Torre, M., Furrow, E., & Foster, J. D. (2022). Effect of urine‐specific gravity on performance of bacteriuria in predicting urine culture results. Journal of Small Animal Practice, 63 (4): 286-292.
[10]Usman, M. W., & Syed, S. R. (2018). Background Evidence to demonstrate the prevalence. Journal of applications in the atmospheric sciences, 32 (14), 2627-2636.
[11]Chu, C. M., & Lowder, J. L. (2018). Diagnosis and treatment of urinary tract infections across age groups. American journal of obstetrics and gynecology, 219 (1): 40–51.
[12]Gupta, K., Grigoryan, L., & Trautner, B. (2017). Urinary Tract Infection. Annals of internal medicine, 167 (7): ITC49–ITC64.
[13]Tenke, P., Köves, B., & Johansen, T. E. (2014). An update on prevention and treatment of catheter-associated urinary tract infections. Current opinion in infectious diseases, 27 (1): 102-107.
[14]Hickling, D. R., Sun, T. T., & Wu, X. R. (2017). Anatomy and physiology of the urinary tract: relation to host defense and microbial infection. Urinary tract infections: Molecular pathogenesis and clinical management, 5 (3): 1-25.
[15]Chaudhari, P. P., Monuteaux, M. C., & Bachur, R. G. (2018). Microscopic bacteriuria detected by automated urinalysis for the diagnosis of urinary tract infection. The Journal of Pediatrics, 202: 238-244.
[16]Jhang, J. F., & Kuo, H. C. (2017). Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention. Tzu-Chi Medical Journal, 29 (3): 131.
[17]McLellan, L. K., & Hunstad, D. A. (2016). Urinary Tract Infection: Pathogenesis and Outlook. Trends in molecular medicine, 22 (11): 946–957.
[18]Medina, M., & Castillo-Pino, E. (2019). An introduction to the epidemiology and burden of urinary tract infections. Therapeutic advances in urology, 11: 175.
[19]Byron J. K. (2019). Urinary Tract Infection. The Veterinary clinics of North America. Small animal practice, 49 (2): 211–221.
[20]Jung, C., & Brubaker, L. (2019). The etiology and management of recurrent urinary tract infections in postmenopausal women. Climacteric, 22 (3): 242-249
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Nnodim Johnkennedy, Adepoju Olorunfemi Itunu, Ikem Promise Amarachi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
